๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2007-01
Trial ID
NCT00548847
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The vast majority of patients with AML will die of the disease, and no stan...
Status
Unknown
Location
Liang Wang
Start Date
2016-01-01
Trial ID
NCT03181815
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2007-12
Trial ID
NCT00602225
Treatments Being Tested
This is a prospective, single-arm, exploratory study evaluating the combina...
Status
Recruiting
Location
Shenzhen University general hospital
Start Date
2026-04-21
Trial ID
NCT07563179
Treatments Being Tested
This study will treat participants with newly diagnosed, low, intermediate ...
Status
Active Not Recruiting
Location
University of Florida Proton Therapy Institute
Start Date
2013-12-04
Trial ID
NCT01871766
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Mayo Clinic
Start Date
1995-10
Trial ID
NCT00002693
Treatments Being Tested
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
Phase I trial to study the effectiveness of augmerosen plus fludarabine and...
Status
Completed
Location
Arthur G. James Cancer Hospital - Ohio State University
Start Date
1999-10
Trial ID
NCT00004862
Treatments Being Tested
Background: Sickle cell disease (SCD) is an inherited disorder of the bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-05-12
Trial ID
NCT05357482
Treatments Being Tested